• Safe DNA Gel Stain: Precision, Safety, and Assay Integrity R

  2026-06-10

  Explore how Safe DNA Gel Stain enables ultra-sensitive DNA and RNA gel staining with minimized mutagenic risk, supporting advanced molecular biology and assay fidelity. Discover unique insights on assay decision-making and workflow safety for modern labs.

• Dissecting Enzalutamide Resistance: Glycan Pathways & AR Tar

  2026-06-10

  This thought-leadership article explores the intersection of androgen receptor (AR) signaling inhibition by MDV3100 (Enzalutamide) and emerging glycosaminoglycan-mediated resistance mechanisms in prostate cancer. It delivers mechanistic insights, actionable protocol guidance, and strategic perspectives for translational researchers seeking to optimize castration-resistant prostate cancer (CRPC) models and overcome therapeutic resistance.

• MOF Nanoparticles for Synergistic Photothermal-Immunotherapy

  2026-06-09

  This study introduces a novel metal-organic framework (MOF) nanoparticle platform that integrates glutathione-responsive, indocyanine green (ICG) loading with PD-1 inhibitory polypeptide AUNP12 modification. By enabling combined photothermal therapy and targeted immunotherapy, these nanoparticles demonstrate enhanced anti-melanoma efficacy and immune activation, offering a promising direction for overcoming tumor recurrence and metastasis.

• Concanavalin A Inhibits Coronavirus Entry via Conserved N-Gl

  2026-06-09

  This study reveals that concanavalin A (ConA) targets phylogenetically conserved N-linked glycans on coronavirus spike proteins, blocking viral entry through inhibition of spike-mediated membrane fusion. The findings highlight a promising glycan-focused approach for broad-spectrum antiviral development, with implications for structural virology and visualization techniques.

• FBXO22 Ligand Discovery Expands Targeted Protein Degradation

  2026-06-08

  This study introduces novel chemical probes for recruiting the E3 ligase FBXO22, including 2-pyridinecarboxaldehyde (2-PCA) as an electrophilic degron. The findings significantly broaden the scope of targeted protein degradation (TPD) beyond established CRBN and VHL systems, enabling new avenues for both mechanistic cancer research and therapeutic development.

• Adenosine Triphosphate (ATP): Beyond Energy—Precision Tools

  2026-06-08

  Explore how Adenosine Triphosphate (ATP) serves not only as a universal energy carrier but also as a precision tool for dissecting mitochondrial regulation and signaling. This article delivers new insights into ATP’s role in advanced cellular metabolism research, grounded in cutting-edge findings and optimized protocols.

• Malate ((S)-2-hydroxysuccinic acid): Experimental Workflows

  2026-06-07

  Malate ((S)-2-hydroxysuccinic acid) empowers researchers to dissect mitochondrial metabolism and immune-metabolic crosstalk with unmatched reproducibility. APExBIO’s malate delivers high solubility and validated batch consistency for advanced metabolic flux and enzyme modulation assays.

• FITC-Concanavalin A (ConA) Conjugate: Technical Application

  2026-06-06

  FITC-Concanavalin A (ConA) Conjugate enables direct, fluorescence-based detection of α-D-glucose and α-D-mannose residues on cell surfaces. It is optimized for immunofluorescence, flow cytometry, and glycobiology research workflows. This reagent should not be used for non-carbohydrate-binding assays or outside its defined stability and storage parameters.

• Clozapine N-oxide (CNO) as a Precision Tool for Circuit-Base

  2026-06-05

  Explore how Clozapine N-oxide (CNO) is transforming circuit-level memory research as a chemogenetic actuator. This article provides in-depth scientific insights into CNO’s unique applications in dissecting memory impairment mechanisms, setting it apart from standard reviews.

• Fe3O4@ZIF-8 Nanoparticles: Dual Antibacterial and Osteogenic

  2026-06-05

  This study introduces Fe3O4@ZIF-8 core–shell nanoparticles with pH-responsive antibacterial and bone regenerative properties for jaw osteomyelitis treatment. By disrupting bacterial membranes via Zn2+ release and supporting bone repair under a magnetic field, this platform addresses persistent infection and bone defect challenges, offering a promising translational advance.

• Docetaxel in Precision Oncology: Mechanisms, Models, and Res

  2026-06-04

  Explore the scientific underpinnings of Docetaxel in cancer chemotherapy research, with a focus on its unique mechanisms, resistance modeling, and translational relevance for breast, ovarian, and prostate cancer studies. This article unveils deeper insights and practical guidance for advanced oncology research.

• Minoxidil Sulphate: Precision Tool for Vascular & Hair Resea

  2026-06-04

  Explore the scientific foundations and advanced applications of Minoxidil sulphate in vascular biology and hair growth research. This in-depth article reveals unique insights into potassium channel modulation, protocol optimization, and translational implications for research teams.

• Advancing In Vitro Cancer Drug Response Evaluation: Insights

  2026-06-03

  Schwartz's dissertation introduces a rigorous framework distinguishing relative viability from fractional viability in in vitro cancer drug assays. This approach enables more precise characterization of anti-proliferative and cytotoxic effects, informing the design and interpretation of experimental studies using compounds such as JNJ-26854165 (Serdemetan).

• HyperFluor 488 Goat Anti-Human IgG Antibody: Workflow Innova

  2026-06-03

  The HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody sets a new benchmark for sensitivity and versatility in translational immunoassays. Optimized for immunofluorescence, Western blotting, and flow cytometry, it delivers robust performance and actionable troubleshooting strategies for high-throughput vaccine research and immune monitoring.

• SIRT7 Mitigates hPDLF Aging and Inflammation via AKT/mTOR Su

  2026-06-02

  The referenced study demonstrates that SIRT7 overexpression reduces aging and inflammatory damage in human periodontal ligament fibroblasts (hPDLFs) by suppressing AKT/mTOR pathway activity. These findings illuminate new mechanistic links in periodontitis pathology and suggest targeted modulation of AKT/mTOR signaling as a promising research avenue for inflammatory and age-associated tissue degeneration.

16192 records 1/1080 page Next 12345 下5页 Last page